Episode Details

Back to Episodes
Flesh-Eating Worms Reach America Yet The Drug They Mock Could Save The Day

Flesh-Eating Worms Reach America Yet The Drug They Mock Could Save The Day

Season 5 Published 2 months, 3 weeks ago
Description

The Biden border crisis isn't just about crime, drugs, and national security anymore. Now America's ranchers, farmers, pet owners, and even families are facing a new threat: the flesh-eating New World screwworm.

After years of an open southern border and unchecked migration from regions where this parasite remains a serious problem, the New World screwworm has now been confirmed inside the United States. The parasite burrows into living tissue, literally eating its host alive. Federal officials are scrambling to contain the outbreak as cases emerge in Texas and New Mexico.

But here's where the story gets even more interesting. The same drug the media, Big Pharma, and the political left spent years demonizing, ivermectin, is now being used as a weapon against the screwworm. In fact, federal authorities have authorized ivermectin-based treatments to help prevent and combat New World screwworm infestations in livestock.

So will the people who mocked ivermectin finally admit they were wrong? Or will politics continue to trump science?

And that's not all. A new observational study examining cancer patients using ivermectin and mebendazole reported an 84% clinical benefit rate, fueling even more questions about whether these inexpensive drugs have far more potential than we've been led to believe. While more research is needed, the findings are impossible to ignore.

Plus, protect yourself and your family with emergency medical kits and wellness products from TWC Health. Use promo code GRANT for 10% off.

Today on Stinchfield, we expose the growing screwworm threat, the border policies that helped create the conditions for it to reach America, and why ivermectin may be one of the most unfairly attacked drugs in modern history.

See omnystudio.com/listener for privacy information.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us